禾元生物-U
(688765)
| 流通市值：28.67亿 | | | 总市值：142.43亿 |
| 流通股本：7197.09万 | | | 总股本：3.58亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 18,274,167.96 | 9,628,104.81 | 47,861,353.23 | 19,660,778.26 |
| 营业收入 | 18,274,167.96 | 9,628,104.81 | 47,861,353.23 | 19,660,778.26 |
| 二、营业总成本 | 110,526,540.09 | 50,498,085.64 | 226,004,752.39 | 152,128,298.94 |
| 营业成本 | 9,351,094.09 | 5,580,708.58 | 30,109,128.44 | 9,813,487.42 |
| 税金及附加 | 1,750,064.96 | 939,535.55 | 2,969,679.86 | 1,879,010.79 |
| 销售费用 | 7,311,008.35 | 1,694,732.17 | 8,696,542.92 | 4,847,569.76 |
| 管理费用 | 39,010,091.07 | 26,057,393.24 | 86,089,854.98 | 59,050,871.71 |
| 研发费用 | 52,385,221.79 | 16,098,856.04 | 92,660,591.42 | 72,533,776.31 |
| 财务费用 | 719,059.83 | 126,860.06 | 5,478,954.77 | 4,003,582.95 |
| 其中:利息费用 | 1,742,632.38 | 714,514.77 | 7,559,677.76 | 5,663,263.43 |
| 其中:利息收入 | 698,095.82 | 479,502.91 | 2,106,491 | 1,713,038.3 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 8,060,063.39 | 4,280,287.26 | 907,526.05 | - |
| 资产处置收益 | 1,311,595.48 | 508,870.1 | 3,788,302.22 | 3,189,411.24 |
| 资产减值损失(新) | -960,008.16 | -698,349.83 | -705,891.77 | -692,022.84 |
| 信用减值损失(新) | 3,184.42 | -11,760.95 | -84,041.01 | -38,621.66 |
| 其他收益 | 19,536,118.14 | 707,738.06 | 16,629,804.13 | 8,737,849.76 |
| 四、营业利润 | -64,301,418.86 | -36,083,196.19 | -157,607,699.54 | -121,270,904.18 |
| 加:营业外收入 | 59,811.44 | 37,264.24 | 570,351.71 | - |
| 减:营业外支出 | -1,485,066.89 | - | - | - |
| 五、利润总额 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| 六、净利润 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| 扣除非经常损益后的净利润 | -88,559,064.1 | -40,760,740.16 | -175,618,075.78 | -131,445,104.18 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.18 | -0.1 | -0.56 | -0.45 |
| (二)稀释每股收益 | -0.18 | -0.1 | -0.56 | -0.45 |
| 九、综合收益总额 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| 归属于母公司股东的综合收益总额 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| 公告日期 | 2026-08-27 | 2026-04-28 | 2026-04-28 | 2025-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |